-
£4.5m for medtech firm to bring world-first implantable brain cancer therapy to clinics
21 Jan 2026 10:48 GMT
… most common type of primary brain cancer in adults and extend potentially … by hard-to-treat glioblastoma (GBM), which Cancer Research UK states … for around 32% of all brain tumours diagnosed in England between 1995 …
-
Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics
21 Jan 2026 08:30 GMT
… brain cancer in adults.
Cancer Research UK says hard-to-treat glioblastoma (GBM … ) accounted for some 32% of all brain tumours diagnosed in … therapy to kill residual brain cancer cells after brain tumour surgery.
QV Bioelectronics says …
-
MedTech developing ‘world-first’ GBM treatment raises £4.5m
21 Jan 2026 19:06 GMT
… help transform treatment for glioblastoma (GBM) and potentially extend thousands of … therapy to kill residual brain cancer cells following brain tumour surgery.
By delivering continual … both newly diagnosed and recurrent GBM.
Early laboratory testing has …
-
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
20 Jan 2026 15:00 GMT
… Preston Robert Tisch Brain Tumor Center has granted … treatment of glioblastoma multiforme (GBM). “Following the successful … aggressive and lethal primary brain tumor. Despite decades of … therapeutic agents directly to brain tumors. The novel approach …
-
Antiques Roadshow star shares 'gory' surgery pic after operation on terminal brain tumour as she asks fans to 'forgive her war wound' - and is flooded with support
20 Jan 2026 13:48 GMT
… and fast-spreading form of brain cancer.
'Glioblastoma is a type … all my friends in the brain tumour community good luck and stable … I was diagnosed with a GBM in June 2022, Jonah was …
-
Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment
22 Jan 2026 16:54 GMT
… common and aggressive type of brain cancer, has a poor prognosis … cell models for aggressive brain tumor, were obtained from the … . Global survival trends for brain tumors, by histology: analysis of … decrease EB1 expression in GBM cells and affect microtubule …
-
Plus Therapeutics Sets 2026 Milestones For REYOBIQ Clinical Program And CNSide Commercial Rollout
22 Jan 2026 15:22 GMT
… expected in Q3 2026.
•ReSPECT-GBM is a Phase 2 trial … in the ReSPECT-PBC pediatric brain cancer Phase 1 trial.
REYOBIQ (rhenium … glioblastoma, leptomeningeal metastases, and pediatric brain cancer.
CNSide Commercialization
•Expand coverage to …
-
Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
22 Jan 2026 12:45 GMT
… the ReSPECT-PBC pediatric brain cancer Phase 1 trial
CNSide … metastases, and pediatric brain cancer in the ReSPECT-GBM, ReSPECT-LM, and … clinical trial for pediatric brain cancer is supported by a … LM) and recurrent glioblastoma (GBM). The Company has built a …
-
BusinessBite: Reporting from Davos – rate of decay outpacing innovation
21 Jan 2026 19:06 GMT
… MedTech developing ‘world-first’ GBM treatment raises £4.5m … transform treatment for glioblastoma (GBM) and potentially extend … around 32% of all brain tumours diagnosed in England between … common type of primary brain cancer in adults, affecting around …
-
Development and Preliminary Validation of a Wearable Tumor Treating Fields Device for Breast Cancer Therapy
21 Jan 2026 15:10 GMT
… or newly diagnosed glioblastoma (GBM), malignant pleural mesothelioma (MPM … newly diagnosed and recurrent GBM patients have been demonstrated … tumor treating fields on brain tumor: a finite element study … on pediatric and adult brain tumors. Int J Mol Sci …